DevOps & Cloud

Deployment, cloud, containers, CI/CD, monitoring, and infrastructure

skills in category: 20,291
pages available: 846

Security grades appear on each card once the skill has been scanned. Newly imported skills may briefly show without a grade until the backfill job runs.

Open in full browser

Browse devops & cloud skills

Showing 9,793–9,816 of 20,291 skills

Endo Vitd No Testing Over75ARecommends against routine 25(OH)D testing in adults aged 75 years and older. Triggered by questions such as "Should I order a vitamin D level for this patient over 75?" or "Is vitamin D testing indicated for asymptomatic elderly adults?"devopsrailstestingVotes: 0GitHub stars: 12
Endo Vitd No Testing 50to74AThis skill recommends against routine 25(OH)D testing in asymptomatic adults aged 50–74 years. It is triggered by questions such as "Should I order a vitamin D level for this patient aged 50-74?" or "Is vitamin D testing indicated for asymptomatic middle-aged adults?"devopsrailstestingVotes: 0GitHub stars: 12
Endo Vit D Supp PregnancyAThe guideline suggests empiric vitamin D supplementation during pregnancy to lower the risk of preeclampsia, intra-uterine mortality, preterm birth, small-for-gestational-age birth, and neonatal mortality. Consider this when a clinician inquires about vitamin D supplementation for pregnant patients to reduce pregnancy complications.devopsrailstestingVotes: 0GitHub stars: 12
Es Tshd Treatment ApproachAThis skill determines the appropriate treatment approach for thyroid-stimulating hormone deficiency (TSHD) in childhood cancer survivors. It recommends using the same levothyroxine dosing and monitoring strategies (e.g., target free T4 levels) as in the noncancer population, triggered by questions such as "How should I treat central hypothyroidism in this survivor?" or "What levothyroxine dose is appropriate for TSHD?"devopsrailsVotes: 0GitHub stars: 12
Es Tshd Screening IndicationAThis skill identifies childhood cancer survivors who require lifelong annual screening for thyroid-stimulating hormone deficiency (TSHD) based on hypothalamic-pituitary tumor history or radiation exposure ≥30 Gy. It is triggered by clinician questions such as “Does this survivor need yearly TSH testing?” or “Is annual thyroid function monitoring indicated post‑HP radiation?”devopsrailstestingVotes: 0GitHub stars: 12
Es Ghd Screening IndicationAThis skill identifies childhood cancer survivors who require lifelong periodic assessment for growth hormone deficiency based on hypothalamic-pituitary tumor history or cranial/spinal radiation exposure ≥18 Gy. It is triggered by questions such as "Does this survivor need GHD screening?" or "Is this patient at risk for growth hormone deficiency post-radiation?"devopsrailstestingVotes: 0GitHub stars: 12
Skills DirectorySkills Directory Look up any of 103,619 scanned skills — grade, score, and every finding. Free.Check a skill
Endo Use Shortacting Octreotide PreconceptionARecommends utilizing short-acting octreotide subcutaneous injections for disease control while awaiting conception after discontinuing long-acting somatostatin receptor ligands or pegvisomant. Trigger phrases include “preconception window,” “discontinuing long-acting SRL,” and “short-acting octreotide as needed until conception.”devopsgoreactVotes: 0GitHub stars: 12
Endo Trial Cabergoline Modest Igf1 MildASuggests a trial of a dopamine agonist, usually cabergoline, as initial adjuvant therapy in patients with only modest IGF-1 elevations and mild GH excess symptoms after surgery. Use when postoperative IGF-1 is mildly elevated and symptoms of GH excess are mild.devopsgorailsVotes: 0GitHub stars: 12
Endo Same Assay MaintenanceAThe skill advises maintaining the same GH and IGF-1 assay throughout a patient's management to ensure comparable serial measurements. Trigger when ordering serial hormone tests for acromegaly monitoring, such as before and after therapy changes or during routine follow-up.devopsrailsVotes: 0GitHub stars: 12
Endo Postop Mri Preferred Ct If ContraAWe need to output a SKILL.md file with the specified<unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk><unk>...devopsgophpVotes: 0GitHub stars: 12
Endo Hypopituitarism Assess ReplaceARecommends assessing for hypopituitarism and replacing hormone deficits in patients with acromegaly at diagnosis and during follow‑up. Triggered by confirmed elevated IGF‑1, post‑surgical or post‑radiation evaluation, or emergence of symptoms such as fatigue, cold intolerance, or loss of libido.devopsgorailsVotes: 0GitHub stars: 12
Endo Avoid Routine Us Gallstones SrlAThis skill advises against routine abdominal ultrasound to screen for gallstone disease in patients receiving somatostatin receptor ligands (SRLs) such as octreotide LAR or lanreotide autogel. Consider this recommendation when planning surveillance imaging for cholelithiasis in asymptomatic SRL-treated acromegaly patients.devopsrailsVotes: 0GitHub stars: 12
Endo Avoid Gh Igf1 Monitoring PregnancyAThis skill advises against measuring GH or IGF-1 in pregnant patients with acromegaly because placental GH variant interferes with assay interpretation. Use when evaluating hormone testing in a pregnant acromegaly patient.devopsrailstestingVotes: 0GitHub stars: 12
Endo Annual Gh Igf1 Post Med Withdrawal Rt EfficacyARecommends annual GH and IGF-1 reassessment following medication withdrawal to assess the efficacy of radiation therapy in patients with acromegaly. Use during long-term follow-up after radiotherapy when evaluating biochemical control after a planned drug-free interval.devopsgorailsVotes: 0GitHub stars: 12
Ata Oral Estrogen Gh DoseASuggests women on oral estrogen replacement receive higher GH doses compared to eugonadal females or males. Triggers when managing GH replacement in a woman on oral estrogen requiring GH therapy (e.g., "female on oral estrogen needing GH replacement").devopsgorailsVotes: 0GitHub stars: 12
Ata No Prescheduled Ddavp PostopARecommends against prescheduled desmopressin (DDAVP) dosing in the first week after pituitary surgery due to hyponatremia risk from transient diabetes insipidus resolution and syndrome of inappropriate antidiuretic hormone secretion occurring 7–10 days postoperatively. Use when managing a postoperative diabetes insipidus patient in the first week after surgery.devopsgorailsVotes: 0GitHub stars: 12
Ata Initial Di Short Acting AdhASuggests initial therapy for diabetes insipidus utilizes short-acting aqueous ADH, allowing safer use in the vast majority of cases where DI resolves spontaneously. Triggers include: new diabetes insipidus diagnosis requiring initial therapy, use when starting diabetes insipidus treatment.devopsrailsVotes: 0GitHub stars: 12
Ata Gh TitrationATitrates GH replacement dose to keep IGF-1 below the upper limit of normal and reduces dose when side effects appear. Use when monitoring GH replacement therapy; triggers include patient on GH replacement needing dose adjustment.devopsrailsVotes: 0GitHub stars: 12
Ata Ddavp Postsurgery TrialAManages post-pituitary surgery diabetes insipidus (DI) to assess recovery of posterior pituitary function. Triggers include managing DI after pituitary surgery requiring assessment of posterior function via DDAVP discontinuation trial.devopsrailsVotes: 0GitHub stars: 12
Ata Acromegaly Gh DoseARecommends low-dose GH replacement in patients with cured acromegaly and documented GHD in the absence of known contraindications. Triggers include managing a cured acromegaly patient with documented growth hormone deficiency.devopsgorailsVotes: 0GitHub stars: 12
Ppgl Hypertensive Crisis ManagementAExecutes the hypertensive crisis management algorithm for PPGL by administering intravenous phentolamine infusion followed by oral doxazosin, with addition of oral beta‑blocker for tachycardia after alpha‑blockade is established. It is triggered by clinical phrases such as 'Patient presents with hypertensive crisis suspected PPGL etiology,' 'Sudden severe hypertension with headache/palpitations,' or 'Intraoperative hypertensive surge during PPGL manipulation.'devopsgorailsVotes: 0GitHub stars: 12
Ppgl Beta Blocker TimingADetermines the appropriate timing for initiating beta-blocker therapy in patients with pheochromocytoma/paraganglioma (PPGL) to prevent hypertensive crisis. Indicated for tachycardia/tachyarrhythmia, myocardial damage, heart failure, or ischemic heart disease only after adequate alpha-blockade; contraindicated before alpha-blocker initiation, and triggered by clinician statements such as “Patient develops tachycardia on alpha-blocker therapy,” “Need to control heart rate in PPGL with cardiac ...devopsrailsVotes: 0GitHub stars: 12
Ppgl Alpha Blocker TitrationATitrates preoperative alpha-blocker dose based on blood pressure response to achieve target hemodynamics (<130/80 mmHg sitting). Increases dose (e.g., doxazosin) every 2‑3 days until target BP is reached, monitoring for orthostatic hypotension and adjusting accordingly; triggers include 'Patient on preoperative alpha-blocker needs dose adjustment,' 'Blood pressure not at target despite current alpha-blocker dose,' 'Assessing need for alpha-blocker titration during preoperative period.'devopsrailstestingVotes: 0GitHub stars: 12
Ata Ppgl Chemotherapy IndicationARecommends CVD chemotherapy as first-line systemic treatment for unresectable pheochromocytoma/paraganglioma with rapid progression or when radionuclide therapy is not applicable. Considers disease progression rate and feasibility to choose between CVD chemotherapy and radionuclide therapy in patients with positive nuclear imaging when progression is slow and radionuclide therapy feasible.devopsrailsapiVotes: 0GitHub stars: 12